NEW YORK, April 22, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding Keurig Green Mountain Inc. (NASDAQ: GMCR), Crown Holdings Inc. (NYSE: CCK), Morgan Stanley (NYSE: MS), MetLife, Inc. (NYSE: MET) and Banco Bradesco S.A. (NYSE: BBD). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1399-100free.
--
Keurig Green Mountain Inc. Analyst Notes
Shares of Keurig Green Mountain Inc. (Keurig) continued the upward movement for the second straight session and gained 0.76% on April 16, 2014, ending the day at $98.13. During the session, the Company's shares opened at $99.02 and oscillated in the range of $95.81 - $99.02. Keurig traded 1.47 million shares during the day. Over the past 12 months, shares of the Company increased 77.00%, as compared to the NASDAQ Composite, which increased 27.51% during the same period. Keurig is a specialty coffee and coffee maker business. The Company will release its financial results for Q2 FY 2014 on May 7, 2014, after market close. The full analyst notes on Keurigare available to download free of charge at:
http://www.analystsreview.com/1399-GMCR-22Apr2014.pdf
--
Crown Holdings Inc. Analyst Notes
On April 16, 2014, Crown Holdings Inc. (Crown Holdings) announced its financial results for Q1 2014. The Company reported a 1.0% YoY increase in net sales to 2.0 billion during the quarter. The increase in sales was primarily driven by increased global beverage can sales unit volumes. Net income attributable to Crown Holdings in Q1 2014 came in at $24 million or $0.17 per diluted share, compared to $41 million or $0.28 per diluted share in Q1 2013. Net income per diluted share before certain items was $0.57 compared to $0.50 in Q1 2013. The analysts polled by Thomson Reuters estimated earnings of $0.51 per share on revenues of $2.02 billion for Q1 2014. The full analyst notes on Crown Holdings are available to download free of charge at:
http://www.analystsreview.com/1399-CCK-22Apr2014.pdf
--
Morgan Stanley Analyst Notes
On April 17, 2014, Morgan Stanley reported its Q1 2014 earnings. On an adjusted basis, Morgan Stanley's net income from continuing operations increased to $1.4 billion from $1.2 billion in Q1 2013. On an adjusted basis, the Company earned $0.68 a share during Q1 2014, an increase from $0.60 a share in the Q1 2013. Morgan Stanley's Common Equity Tier 1 capital ratio was approximately 14.1% and its Tier 1 capital ratio was nearly 15.6% at March 31, 2014. The firm increased its quarterly dividend to $0.10 per share, payable on May 15, 2014 to common shareholders of record on April 30, 2014 and also announced a $1 billion share repurchase program, both approved by the U.S. Federal Reserve in the month of March this year. The full analyst notes on Morgan Stanley are available to download free of charge at:
http://www.analystsreview.com/1399-MS-22Apr2014.pdf
--
MetLife, Inc. Analyst Notes
On April 1, 2014, Bloomberg reported that MetLife, Inc. (MetLife) will have to pay $60 million after New York regulators found that MetLife's subsidiaries solicited business without a license in the state and made intentional misrepresentations to regulators. The news report on Bloomberg stated that MetLife has also agreed to cooperate with the Department of Financial Services (DFS) investigation into AIG, which sold the businesses to MetLife in 2010. MetLife will pay $50 million to DFS and $10 million to the Manhattan District Attorney's Office. The full analyst notes on MetLife are available to download free of charge at:
http://www.analystsreview.com/1399-MET-22Apr2014.pdf
--
Banco Bradesco S.A. Analyst Notes
On April 11, 2014, Banco Bradesco S.A. (Banco Bradesco) announced that it will hold a Conference Call in English to announce the Q1 2014 earnings results on April 25, 2014, at 10:00 a.m. (U.S. ET). Further, the Company informed that its Portuguese Conference Call will also be held on the same day at 8:00 a.m. (U.S. ET). According to Zacks Investment Research, the consensus EPS estimate for Q1 2014 is $0.34. The full analyst notes on Banco Bradesco are available to download free of charge at:
http://www.analystsreview.com/1399-BBD-22Apr2014.pdf
--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Namrata Maheshwari, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
